Anjani Portland Cement Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 21, 2025, 5:57 am

Quick Insight

Anjani Portland Cement Ltd, with a market capitalization of ₹425 Cr. and a share price of 147, presents a mixed financial picture. While the company boasts a healthy ROE of 31.8% and a P/BV ratio of 1.68x, its negative operating profit margin (-4%) and significant net profit decline of 81% raise concerns about operational efficiency and profitability. Furthermore, Anjani's high level of borrowings at ₹463 Cr. and a low interest coverage ratio of 0.92x indicate potential liquidity and solvency risks. Investors should closely monitor the company's ability to improve operational performance and manage its debt levels to ensure long-term sustainability and value creation.

Competitors of Anjani Portland Cement Ltd

All Competitor Stocks of Anjani Portland Cement Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:50 pm

Below is a detailed analysis of the quarterly data for Anjani Portland Cement Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 139.53 Cr.. The value appears strong and on an upward trend. It has increased from 138.87 Cr. (Mar 2025) to 139.53 Cr., marking an increase of 0.66 Cr..
• For Expenses, as of Jun 2025, the value is 127.08 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 143.73 Cr. (Mar 2025) to 127.08 Cr., marking a decrease of 16.65 Cr..
• For Operating Profit, as of Jun 2025, the value is 12.45 Cr.. The value appears strong and on an upward trend. It has increased from -4.86 Cr. (Mar 2025) to 12.45 Cr., marking an increase of 17.31 Cr..
• For OPM %, as of Jun 2025, the value is 8.92%. The value appears strong and on an upward trend. It has increased from -3.50% (Mar 2025) to 8.92%, marking an increase of 12.42%.
• For Other Income, as of Jun 2025, the value is 0.18 Cr.. The value appears to be declining and may need further review. It has decreased from 0.27 Cr. (Mar 2025) to 0.18 Cr., marking a decrease of 0.09 Cr..
• For Interest, as of Jun 2025, the value is 8.60 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.35 Cr. (Mar 2025) to 8.60 Cr., marking an increase of 0.25 Cr..
• For Depreciation, as of Jun 2025, the value is 8.61 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.28 Cr. (Mar 2025) to 8.61 Cr., marking a decrease of 2.67 Cr..
• For Profit before tax, as of Jun 2025, the value is -4.58 Cr.. The value appears strong and on an upward trend. It has increased from -24.22 Cr. (Mar 2025) to -4.58 Cr., marking an increase of 19.64 Cr..
• For Tax %, as of Jun 2025, the value is -24.67%. The value appears to be increasing, which may not be favorable. It has increased from -45.91% (Mar 2025) to -24.67%, marking an increase of 21.24%.
• For Net Profit, as of Jun 2025, the value is -3.45 Cr.. The value appears strong and on an upward trend. It has increased from -13.10 Cr. (Mar 2025) to -3.45 Cr., marking an increase of 9.65 Cr..
• For EPS in Rs, as of Jun 2025, the value is -1.16. The value appears strong and on an upward trend. It has increased from -4.42 (Mar 2025) to -1.16, marking an increase of 3.26.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 6:08 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:29 pm

Below is a detailed analysis of the balance sheet data for Anjani Portland Cement Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 29.00 Cr..
• For Reserves, as of Mar 2025, the value is 184.00 Cr.. The value appears to be declining and may need further review. It has decreased from 265.00 Cr. (Mar 2024) to 184.00 Cr., marking a decrease of 81.00 Cr..
• For Borrowings, as of Mar 2025, the value is 463.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 427.00 Cr. (Mar 2024) to 463.00 Cr., marking an increase of 36.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 266.00 Cr.. The value appears to be improving (decreasing). It has decreased from 280.00 Cr. (Mar 2024) to 266.00 Cr., marking a decrease of 14.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 943.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,001.00 Cr. (Mar 2024) to 943.00 Cr., marking a decrease of 58.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 812.00 Cr.. The value appears to be declining and may need further review. It has decreased from 847.00 Cr. (Mar 2024) to 812.00 Cr., marking a decrease of 35.00 Cr..
• For CWIP, as of Mar 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 7.00 Cr., marking an increase of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 125.00 Cr.. The value appears to be declining and may need further review. It has decreased from 151.00 Cr. (Mar 2024) to 125.00 Cr., marking a decrease of 26.00 Cr..
• For Total Assets, as of Mar 2025, the value is 943.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,001.00 Cr. (Mar 2024) to 943.00 Cr., marking a decrease of 58.00 Cr..

However, the Borrowings (463.00 Cr.) are higher than the Reserves (184.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Anjani Portland Cement Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is -13.30. This value is below the healthy minimum of 5. It has increased from -22.35 (Mar 23) to -13.30, marking an increase of 9.05.
• For Diluted EPS (Rs.), as of Mar 24, the value is -13.30. This value is below the healthy minimum of 5. It has increased from -22.35 (Mar 23) to -13.30, marking an increase of 9.05.
• For Cash EPS (Rs.), as of Mar 24, the value is 2.99. This value is below the healthy minimum of 3. It has increased from -1.62 (Mar 23) to 2.99, marking an increase of 4.61.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 101.17. It has decreased from 114.63 (Mar 23) to 101.17, marking a decrease of 13.46.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 101.17. It has decreased from 114.63 (Mar 23) to 101.17, marking a decrease of 13.46.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 212.43. It has decreased from 225.23 (Mar 23) to 212.43, marking a decrease of 12.80.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 10.19. This value is within the healthy range. It has increased from 8.20 (Mar 23) to 10.19, marking an increase of 1.99.
• For PBIT / Share (Rs.), as of Mar 24, the value is -6.19. This value is below the healthy minimum of 0. It has increased from -10.10 (Mar 23) to -6.19, marking an increase of 3.91.
• For PBT / Share (Rs.), as of Mar 24, the value is -17.15. This value is below the healthy minimum of 0. It has increased from -21.84 (Mar 23) to -17.15, marking an increase of 4.69.
• For Net Profit / Share (Rs.), as of Mar 24, the value is -13.39. This value is below the healthy minimum of 2. It has increased from -19.92 (Mar 23) to -13.39, marking an increase of 6.53.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -13.30. This value is below the healthy minimum of 2. It has increased from -19.80 (Mar 23) to -13.30, marking an increase of 6.50.
• For PBDIT Margin (%), as of Mar 24, the value is 4.79. This value is below the healthy minimum of 10. It has increased from 3.64 (Mar 23) to 4.79, marking an increase of 1.15.
• For PBIT Margin (%), as of Mar 24, the value is -2.91. This value is below the healthy minimum of 10. It has increased from -4.48 (Mar 23) to -2.91, marking an increase of 1.57.
• For PBT Margin (%), as of Mar 24, the value is -8.07. This value is below the healthy minimum of 10. It has increased from -9.69 (Mar 23) to -8.07, marking an increase of 1.62.
• For Net Profit Margin (%), as of Mar 24, the value is -6.30. This value is below the healthy minimum of 5. It has increased from -8.84 (Mar 23) to -6.30, marking an increase of 2.54.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is -6.26. This value is below the healthy minimum of 8. It has increased from -8.78 (Mar 23) to -6.26, marking an increase of 2.52.
• For Return on Networth / Equity (%), as of Mar 24, the value is -13.26. This value is below the healthy minimum of 15. It has increased from -17.42 (Mar 23) to -13.26, marking an increase of 4.16.
• For Return on Capital Employeed (%), as of Mar 24, the value is -2.26. This value is below the healthy minimum of 10. It has increased from -3.61 (Mar 23) to -2.26, marking an increase of 1.35.
• For Return On Assets (%), as of Mar 24, the value is -3.90. This value is below the healthy minimum of 5. It has increased from -5.58 (Mar 23) to -3.90, marking an increase of 1.68.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 1.38. This value exceeds the healthy maximum of 1. It has increased from 1.13 (Mar 23) to 1.38, marking an increase of 0.25.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.45. This value exceeds the healthy maximum of 1. It has increased from 1.31 (Mar 23) to 1.45, marking an increase of 0.14.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.61. There is no change compared to the previous period (Mar 23) which recorded 0.61.
• For Current Ratio (X), as of Mar 24, the value is 0.68. This value is below the healthy minimum of 1.5. It has increased from 0.65 (Mar 23) to 0.68, marking an increase of 0.03.
• For Quick Ratio (X), as of Mar 24, the value is 0.39. This value is below the healthy minimum of 1. It has increased from 0.34 (Mar 23) to 0.39, marking an increase of 0.05.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.17. This value is below the healthy minimum of 4. It has decreased from 1.20 (Mar 23) to 1.17, marking a decrease of 0.03.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 0.92. This value is below the healthy minimum of 3. It has increased from 0.69 (Mar 23) to 0.92, marking an increase of 0.23.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -0.22. This value is below the healthy minimum of 3. It has increased from -0.69 (Mar 23) to -0.22, marking an increase of 0.47.
• For Enterprise Value (Cr.), as of Mar 24, the value is 921.48. It has increased from 859.28 (Mar 23) to 921.48, marking an increase of 62.20.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.48. This value is within the healthy range. It has increased from 1.30 (Mar 23) to 1.48, marking an increase of 0.18.
• For EV / EBITDA (X), as of Mar 24, the value is 30.78. This value exceeds the healthy maximum of 15. It has decreased from 35.68 (Mar 23) to 30.78, marking a decrease of 4.90.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 23) to 0.79, marking an increase of 0.16.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Price / BV (X), as of Mar 24, the value is 1.68. This value is within the healthy range. It has increased from 1.26 (Mar 23) to 1.68, marking an increase of 0.42.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 23) to 0.79, marking an increase of 0.16.
• For EarningsYield, as of Mar 24, the value is -0.07. This value is below the healthy minimum of 5. It has increased from -0.13 (Mar 23) to -0.07, marking an increase of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness